Latest Trials

EudraCT Number: 2006-003929-83 Sponsor Protocol Number: ML 20469/GOIRC Start Date: 2006-11-23
Sponsor Name: GRUPPO ONCOLOGICO ITALIANO DI RICERCA
Full Title: Phase II study of Bevacizumab in combination with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer.
Medical condition: Patients with advanced breast cancer
Disease: Version SOC Term Classification Code Term Level
9.1 10006187 Breast cancer LLT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-005077-29 Sponsor Protocol Number: D4200C00058 Start Date: 2006-11-23
Sponsor Name: AstraZeneca AB
Full Title: An International, Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMA ) versus Placebo in Subjects with Unresectable Locally Adva...
Medical condition: Medullary thyroid cancer
Disease: Version SOC Term Classification Code Term Level
15.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10027105 Medullary thyroid cancer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) NL (Ongoing) FR (Ongoing) BE (Ongoing) HU (Completed) PT (Ongoing) SE (Ongoing) DK (Completed) AT (Completed) IT (Completed) GB (Completed) CZ (Completed) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-003748-43 Sponsor Protocol Number: TKA 4 Start Date: 2006-11-23
Sponsor Name: Ortopædkirurgisk Center, Aarhus Universitets Hospital
Full Title: Kan topical bisfosfonat øge fiksation og overlevelse af ucementeret knæledsprotese? Et prospektivt randomiseret migrations- og knogledensitetsstudie på tibia-implantater af trabeculært metal.
Medical condition: Osteoarthritis of the knee treated with knee alloplastic
Disease: Version SOC Term Classification Code Term Level
8.1 10031200 Osteoarthrosis, localized, primary, involving lower leg LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-003255-20 Sponsor Protocol Number: CRAD001C2241 Start Date: 2006-11-23
Sponsor Name: NOVARTIS FARMA
Full Title: A single arm, multicenter phase II study of RAD001 in patients with metastatic colorectal adenocarcinoma whose cancer has progressed despite prior therapy with an anti-EGFR antibody (if appropriate...
Medical condition: metastatic colorectal adenocarcinoma
Disease: Version SOC Term Classification Code Term Level
9.1 10051925 Intestinal adenocarcinoma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2006-000606-23 Sponsor Protocol Number: 26756 Start Date: 2006-11-23
Sponsor Name: Merck, S.L.
Full Title: Post-authorization safety study to check the potential association between the safety profile of beta interferon 1a and the body mass index or pharmacodynamics during the titration phase
Medical condition: Not applicalbe
Disease: Version SOC Term Classification Code Term Level
14.1 10029205 - Nervous system disorders 10028245 Multiple sclerosis PT
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2006-003512-22 Sponsor Protocol Number: 0869-130 Start Date: 2006-11-23
Sponsor Name: Laboratoires Merck Sharp & Dohme-Chibret
Full Title: A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nau...
Medical condition: Chemotherapy-induced Nausea and Vomitting
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Completed) DE (Completed)
Trial results: View results
EudraCT Number: 2005-003819-71 Sponsor Protocol Number: DX-88/14 Start Date: 2006-11-23
Sponsor Name: Dyax Corp
Full Title: EDEMA3: Evaluation of DX-88’s Effects in Mitigating Angioedema A double-blind, placebo-controlled study followed by a repeat dosing phase to assess the efficacy and safety of DX-88 (recombinant pl...
Medical condition: Hereditary Angioedema
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: BE (Completed) GB (Completed) IT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-001595-20 Sponsor Protocol Number: CRAD001J2102 Start Date: 2006-11-23
Sponsor Name: NOVARTIS FARMA
Full Title: A phase Ib study investigating the combination of RAD001 with trastuzumab and vinorelbine in patients with HER2- overexpressing metastatic breast cancer
Medical condition: HER2 overexpressing metastatic breast cancer
Disease: Version SOC Term Classification Code Term Level
9.1 10021977 Inflammatory carcinoma of breast recurrent LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2006-002335-24 Sponsor Protocol Number: 13362B Start Date: 2006-11-23
Sponsor Name: University of Chicago
Full Title: A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck Cancer Estudio de fase III randomizado de una quimioterapia de inducción...
Medical condition: Phase III trial of induction therapy with docetaxel followed by chemoradiotherapy versus chemoradiotherapy alone in patients with nodal stage N2 or N3 head and neck cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-005494-21 Sponsor Protocol Number: MARIA Start Date: 2006-11-23
Sponsor Name: HYKS Marian sairaala
Full Title: Hyperbaarisen artikaiini-glukoosiliuoksen ja pelkän artikaiinin vertailu spinaalipuudutuksessa nivustyräpotilailla
Medical condition: nivustyrä
Disease: Version SOC Term Classification Code Term Level
8.1 10019909 Hernia LLT
Population Age: Adults Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe